Bitnomial Launches First U.S. Regulated INJ Futures

Bitnomial, a CFTC-regulated designated contract market, listed the monthly-expiring contracts on April 15, 2026. Institutional clients gained immediate access through clearing member Futures Commission Merchants. Retail traders followed via Bitnomial’s Botanical platform in subsequent weeks.

Injective confirmed today on X that regulated INJ futures “have officially started trading” on the platform. The listing places INJ alongside Bitcoin, Ethereum, Solana, and XRP. Those are the only other digital assets with CFTC-regulated futures in the U.S.

How the Regulated INJ Futures Work

The contracts settle in INJ, not cash. Traders can post margin in either crypto assets or USD through Bitnomial Clearinghouse, LLC. Platform-wide leverage reaches up to 6x on supported products, according to Bitnomial’s product page.

Eligibility extends to U.S. institutional and retail participants who meet Bitnomial’s onboarding and FCM requirements. Non-U.S. users may also access the contracts subject to local regulations.

Bitnomial plans to add INJ perpetual futures and options later, according to the official announcement. Exact contract size and maximum leverage for INJ were not detailed in the launch materials.

Why This Listing Matters for Injective

CFTC-regulated futures differ sharply from unregulated perpetuals on offshore exchanges. Regulated contracts operate under position limits, reporting requirements, and customer protections. This gives compliant U.S. institutions a way to gain INJ exposure or hedge positions without direct spot ownership.

Eric Chen, co-founder of Injective, called the listing “a critical milestone for any digital asset seeking broad institutional participation.” He added that it “validates the demand for institutional-grade access to Injective” in the April 15 press release.

Michael Dunn, president of Bitnomial Exchange, praised Injective’s technical design. He described it as a technically ambitious Layer-1 blockchain with an on-chain order book, cross-chain execution, and near-zero gas fees designed for financial applications.

The ETF Connection

Dunn also pointed to a potential spot ETF pathway. He said the listing “adds another building block toward a potential spot ETF under the SEC’s generic listing standards.”

Regulated futures trading history played a key role in both the Bitcoin and Ethereum ETF approvals. The BTC ETF followed years of CME futures trading data. Ethereum’s ETF came after Ether futures gained traction on the same exchange. Both cases showed regulators that a mature derivatives market reduces manipulation risk in the underlying spot market.

Canary Capital filed for a staked INJ ETF in 2025. A track record of regulated INJ futures trading could strengthen that application, though the timeline remains uncertain. The CFTC license treats INJ as a commodity rather than a security, which provides regulatory clarity for derivatives.

Injective’s Technical Foundation

Injective launched in 2018 through Binance Labs’ first incubator program. Co-founders Eric Chen and Albert Chon built it as a Layer-1 blockchain purpose-built for financial applications.

The protocol features a fully on-chain order book and sub-second finality. It also supports interoperability across IBC, Ethereum, and Solana. The team raised a seed round from Pantera Capital and Hashed in 2019, then a $10 million round in 2021 that included Mark Cuban.

Institutional validators include Google Cloud and Binance. According to DefiLlama data, Injective’s DeFi TVL sits at approximately $14.37 million, with a stablecoin market cap near $15.75 million. Historical staking has reached roughly 62.5% of circulating supply.

Market Reaction and On-Chain Data

On the April 15 launch day, INJ rose approximately 3.89% to around $3.20. The market cap sat near $320 million at the time. The 24-hour on-chain perpetuals volume on Injective stood at $1.15 million. No significant whale movements, staking spikes, or supply shocks tied to the launch appeared in recent on-chain reports.

Coverage from CoinMarketCap Academy, Cointelegraph, and TradingView uniformly described the launch as the first U.S.-regulated INJ futures. No conflicting accounts from major outlets such as CoinDesk, The Block, or Bloomberg surfaced.

Community sentiment on X, Reddit, and Discord skews strongly bullish. Users highlight institutional access, the ETF pathway, and Injective’s infrastructure focus. Some analysts noted the listing as “quietly significant” rather than hype-driven. KOLs and ambassadors called the regulatory milestone “massive” and a sign of how institutions evaluate the project.

What Comes Next for Regulated INJ Futures

Bitnomial’s next steps include adding perpetual futures and options for INJ. Daily trading volumes and precise leverage limits for the INJ contracts have not been disclosed yet.

The regulated futures listing starts a clock that ETF watchers will monitor closely. If Bitnomial’s INJ contracts build meaningful volume, they could support the case for a spot INJ ETF down the line.

For now, INJ sits in a small but growing club of digital assets with CFTC-regulated derivatives access. That distinction may prove more valuable than any single-day price move.

This article is for informational purposes only and does not constitute financial advice. Always do your own research before making investment decisions.